Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-associated mortality in the US. Previously, we established an immune-mediated TRALI mouse model, wherein mice with cognate antigen were challenged with MHC class I mAb. In this study, when mice housed in a rodent, specific pathogen–free barrier room were challenged with MHC I mAb, there was significant protection from TRALI compared with nonbarrier mice. Priming mice with LPS restored lung injury with mAb challenge. Using TLR4-deficient bone marrow chimeras, the priming phenotype was restricted to animals with WT hematopoietic cells, and depletion of either neutrophils or platelets was protective. Both neutrophils and platelets were sequestered in the lungs of mice with TRALI, and retention of platelets was neutrophil dependent. Interestingly, treatment with aspirin prevented lung injury and mortality, but blocking the P selectin or CD11b/CD18 pathways did not. These data suggest a 2-step mechanism of TRALI: priming of hematopoietic cells, followed by vascular deposition of activated neutrophils and platelets that then mediate the severe lung injury. Furthermore, our data offer an explanation for the increased incidence of TRALI in patients with immune priming conditions, and we suggest what we believe to be a novel therapeutic approach.
Mark R. Looney, John X. Nguyen, Yongmei Hu, Jessica A. Van Ziffle, Clifford A. Lowell, Michael A. Matthay
Title and authors | Publication | Year |
---|---|---|
Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation
Guadalupe Ortiz-Munoz, Michelle A. Yu, Emma Lefrançais, Benat Mallavia, Colin Valet, Jennifer J. Tian, Serena Ranucci, Kristin M. Wang, Zhe Liu, Nicholas Kwaan, Diana Dawson, Mary Ellen Kleinhenz, Fadi T. Khasawneh, Peter M. Haggie, Alan S. Verkman, Mark R. Looney |
Journal of Clinical Investigation | 2020 |
Complement activation on endothelium initiates antibody-mediated acute lung injury
Simon J. Cleary, Nicholas Kwaan, Jennifer J. Tian, Daniel R. Calabrese, Beñat Mallavia, Mélia Magnen, John R. Greenland, Anatoly Urisman, Jonathan P. Singer, Steven R. Hays, Jasleen Kukreja, Ariel M. Hay, Heather L. Howie, Pearl Toy, Clifford A. Lowell, Craig N. Morrell, James C. Zimring, Mark R. Looney |
Journal of Clinical Investigation | 2020 |
Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation
EA van der Laan, S van der Velden, AE Bentlage, MD Larsen, TL van Osch, JY Mok, G Brasser, DM Geerdes, CA Koeleman, J Nouta, JW Semple, L Porcelijn, WJ van Esch, M Wuhrer, CE van der Schoot, G Vidarsson, R Kapur |
Blood Advances | 2020 |
Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation
JM Adrover, A Aroca-Crevillén, G Crainiciuc, F Ostos, Y Rojas-Vega, A Rubio-Ponce, C Cilloniz, E Bonzón-Kulichenko, E Calvo, D Rico, MA Moro, C Weber, I Lizasoaín, A Torres, J Ruiz-Cabello, J Vázquez, A Hidalgo |
Nature Immunology | 2020 |
Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
H Liang, X Ding, H Li, L Li, T Sun |
Frontiers in pharmacology | 2020 |
Haem oxygenase protects against thrombocytopaenia and malaria-associated lung injury
IG de Azevedo-Quintanilha, IM Medeiros-de-Moraes, AC Ferreira, PA Reis, A Vieira-de-Abreu, RA Campbell, AS Weyrich, PT Bozza, GA Zimmerman, HC Castro-Faria-Neto |
Malaria Journal | 2020 |
Antiplatelet Therapy for Acute Respiratory Distress Syndrome
CM Chen, HC Lu, YT Tung, W Chen |
Biomedicines | 2020 |
Revisiting Platelets and Toll-Like Receptors (TLRs): At the Interface of Vascular Immunity and Thrombosis
K Hally, S Fauteux-Daniel, H Hamzeh-Cognasse, P Larsen, F Cognasse |
International journal of molecular sciences | 2020 |
Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)
EA van der Laan, S van der Velden, L Porcelijn, JW Semple, CE van der Schoot, R Kapur |
Transfusion Medicine Reviews | 2020 |
Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2
A Constantinescu-Bercu, L Grassi, M Frontini, II Salles-Crawley, K Woollard, JT Crawley |
eLife | 2020 |
Neutrophil Adaptations upon Recruitment to the Lung: New Concepts and Implications for Homeostasis and Disease
VD Giacalone, C Margaroli, MA Mall, R Tirouvanziam |
International journal of molecular sciences | 2020 |
The Role of Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms
Z Cahilog, H Zhao, L Wu, A Alam, S Eguchi, H Weng, D Ma |
Inflammation | 2020 |
Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS
S Zhang, Z Lu, Z Wu, J Xie, Y Yang, H Qiu |
Frontiers in Medicine | 2020 |
Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
SJ Cleary, SC Pitchford, RT Amison, R Carrington, CL Cabrera, M Magnen, MR Looney, E Gray, CP Page |
British Journal of Pharmacology | 2020 |
The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities
S Fiorino, M Zippi, C Gallo, D Sifo, S Sabbatani, R Manfredi, E Rasciti, L Rasciti, E Giampieri, I Corazza, P Leandri, D de Biase |
British Journal of Nutrition | 2020 |
A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries
D Lv, Y Xu, H Cheng, Y Ke, X Zhang, K Ying |
Experimental Cell Research | 2020 |
Lymphatic Flow: A Potential Target in Sepsis-Associated Acute Lung Injury C Wu, H Li, P Zhang, C Tian, J Luo, W Zhang, S Bhandari, S Jin, Y Hao |
Journal of inflammation research | 2020 |
Disease Mechanisms of Perioperative Organ Injury
C Conrad, HK Eltzschig |
Anesthesia & Analgesia | 2020 |
Platelet activation in experimental murine neonatal pulmonary hypertension.
Davizon-Castillo P, Allawzi A, Sorrells M, Fisher S, Baltrunaite K, Neeves K, Nozik-Grayck E, DiPaola J, Delaney C |
Physiological Reports | 2020 |
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH |
Thrombosis and haemostasis | 2020 |
Anti-Inflammatory and Reactive Oxygen Species Suppression through Aspirin Pretreatment to Treat Hyperoxia-Induced Acute Lung Injury in NF-κB–Luciferase Inducible Transgenic Mice
Chen CM, Tung YT, Wei CH, Lee PY, Chen W |
Antioxidants | 2020 |
Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome.
Mahida RY, Matsumoto S, Matthay MA |
American journal of respiratory cell and molecular biology | 2020 |
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
Horowitz RI, Freeman PR |
Medical Hypotheses | 2020 |
Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice
Guo J, Li M, Yang Y, Zhang L, Zhang LW, Sun QY |
BMC Pulmonary Medicine | 2020 |